Profile
Joël Richard is currently a member of the Scientific & Medical Council at GlioCure SAS. He previously worked as the Managing Director at OctreoPharm Sciences GmbH, Development Director at Ipsen Dreux, and Senior Vice President-Pharma Development at Ipsen SA. He is also currently serving as the Chief Scientific Officer at MedinCell SA, a position he has held since 2022 and will continue until 2023.
Joël Richard active positions
| Companies | Position | Start |
|---|---|---|
GlioCure SAS
GlioCure SAS BiotechnologyHealth Technology Operates as a biopharmaceutical company specializing in the discovery and development of new drugs targeting glioma and pediatric brain tumors | Corporate Officer/Principal | - |
Former positions of Joël Richard
| Companies | Position | End |
|---|---|---|
| MEDINCELL S.A. | Chief Tech/Sci/R&D Officer | 01/02/2023 |
| IPSEN | Corporate Officer/Principal | - |
Ipsen Dreux | Corporate Officer/Principal | - |
OctreoPharm Sciences GmbH
OctreoPharm Sciences GmbH Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Chief Executive Officer | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 5 |
|---|---|
Ipsen SA
Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
OctreoPharm Sciences GmbH
OctreoPharm Sciences GmbH Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
MedinCell SA
MedinCell SA Pharmaceuticals: MajorHealth Technology Provides therapeutic solutions | Health Technology |
GlioCure SAS
GlioCure SAS BiotechnologyHealth Technology Operates as a biopharmaceutical company specializing in the discovery and development of new drugs targeting glioma and pediatric brain tumors | Health Technology |
Ipsen Dreux |
- Stock Market
- Insiders
- Joël Richard
















